期刊文献+

自乳化药物传递系统的生物药剂学性质概述 被引量:5

An Update of the Biopharmaceutical Aspects of Self-emulsifying Drug Delivery Systems
下载PDF
导出
摘要 自乳化药物传递系统因其能增加难溶性和亲脂性药物体内生物利用度,一直都是研究的热点。本综述总结了自乳化药物传递系统的生物药剂学性质,为研究自乳化药物传递系统提高药物生物利用度的机制提供参考。 The self-emulsifying drug delivery system has always been a hot area in the study of the insoluble and lipophilic drugs for improving the oral bioavailability of these drug. This article aims to summarize the biopharmaceutical aspects of self-emulsifying drug delivery systems, which provides a reference of studying the mechanism of increase oral bioavailability by self-emulsifying drug delivery system.
作者 文晓霞 夏玉凤 WEN Xiao-xia;XlA Yu-feng(Department of Chinese Materia Medica Analysis, China Pharmaceutical University, Nanjing 2]0009, Chin)
出处 《海峡药学》 2018年第4期4-7,共4页 Strait Pharmaceutical Journal
关键词 自乳化药物传递系统 生物药剂学 生物利用度 机制 Self-emulsifying drug delivery system Biopharmaceutical aspects Bioavailability Mechanism
  • 相关文献

参考文献2

二级参考文献11

  • 1张继明,胡富强,应晓英,袁弘.胰岛素固体脂质纳米粒的制备及其理化性质研究[J].中国药学杂志,2004,39(8):605-607. 被引量:16
  • 2A van Helvoort, AJ Smith, H Sprong, et al. MDR1 P- glycoprotein is a lipid translocase of broad specificity, while MDR3 P - glycoprotein specifically translocates phosphatidylcholine[ J]. Cell, 1996,87:507.
  • 3GRASS GM. In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell[ J]. Pharm Res, 1988,5:372.
  • 4SHINO Y. Modulation of intestinal P - glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes [ J ]. Pharm Sci,2004,93(4) :877.
  • 5Johnson BM. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d - alpha - tocopheryl polyethylene glycol 1000 succinate on P- glycoprotein efflux and enterocyte - based metabolism in excised rat intestine[J]. AAPS PharmSci,2002,4(4) :40.
  • 6Fontaine M. Use of rhodamine 123 to examine the functional activity of P - glycoprotein in primary cultured brain microvessel endothelial cell monolayers[ J]. Life Sci, 1996,59(18): 1521.
  • 7koga K. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine[J]. Eur J Pharm Biopharm,2002,54(3) :311.
  • 8S Eaimtrakarn, YV Rama Prasad, T Ohno, et al. Absorption enhancing effect of Labrasol on the intestinal absorption of insulin[J]. Drug Target, 2002,10:255.
  • 9YV Rama Prasad, SP Puthli, S Eaimtrakarn, et al. Enhanced intestinal absorption of Vancomycin with Labrasol and - - tocopheryl PEG 1000 succinate in rats[J]. Int Pharm,2003,250:181.
  • 10RAMA. In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer [ J ]. Int J Pharm, 2004,271( 1 - 2) :225.

共引文献6

同被引文献56

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部